The U.S. Food and Drug Administration (FDA) has accepted an application from Corcept Therapeutics seeking the approval of…
Articles by Marisa Wexler, MS
Sterotherapeutics has announced the launch of a Phase 2 clinical trial to test its experimental therapy ST-002 in…
In rare cases, Cushing’s syndrome can be caused by tumors that are simultaneously producing two signaling molecules called adrenocorticotropic hormone…
Differences in the levels of hormones made by the adrenal glands, which sit atop the kidneys, may explain why bone…
Long-term treatment with Isturisa (osilodrostat) may help lower blood pressure, and blood sugar, levels in people with Cushing’s…
People with Cushing’s syndrome are at an increased risk of experiencing dangerous blood clotting events in the years following diagnosis,…
A rare and aggressive form of thyroid cancer caused Cushing’s syndrome in a man in his 30s, according to a…
Corcept Therapeutics has asked the U.S. Food and Drug Administration (FDA) to approve relacorilant for people with endogenous…
People with Cushing’s disease frequently experience cognitive and psychiatric complications, often persisting after surgery to remove the disease-driving tumor,…
Changes in gut bacteria may underlie the development of mental health problems in people with Cushing’s disease, a study…